Multiple Myeloma Patients Display Weakened Antibody Responses to mRNA COVID Vaccines
|

Multiple Myeloma Patients Display Weakened Antibody Responses to mRNA COVID Vaccines

A new study reports weakened antibody responses to COVID-19 mRNA vaccines among most patients with multiple myeloma, a common form of bone-marrow cancer associated with an immunocompromised state. The research, scheduled for publication by the journal Leukemia, was carried out at the Institute for Myeloma & Bone Cancer Research (IMBCR) in West Hollywood, California under the direction of James…